Exploring the significance of PAK1 through chromosome conformation signatures in ibrutinib‐resistant chronic lymphocytic leukaemia

Ibrutinib exerts promising anticancer effects in chronic lymphocytic leukaemia (CLL). However, acquired resistance occurs during treatment, necessitating the exploration of underlying mechanisms. Although three‐dimensional genome organization has been identified as a major player in the development...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Zijuan, Wang, Luqiao, Fan, Lei, Tang, Hanning, Zuo, Xiaoling, Gu, Danling, Lu, Xueying, Li, Yue, Wu, Jiazhu, Qin, Shuchao, Xia, Yi, Zhu, Huayuan, Wang, Li, Xu, Wei, Li, Jianyong, Jin, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9394240/
https://www.ncbi.nlm.nih.gov/pubmed/35811334
http://dx.doi.org/10.1002/1878-0261.13281

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9394240/
https://www.ncbi.nlm.nih.gov/pubmed/35811334
http://dx.doi.org/10.1002/1878-0261.13281

Ejemplares similares